The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

BDX

Concerning the House

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

United States · www.bd.com

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$21.84B+7.2%
Gross profit$1.66B+9.7%
Operating income$2.40B+2.8%
Net income$1.68B+5.4%
Cash from ops$3.33B+5.4%
Quotation

$181.97

-1.61 (-0.9%)

52w hi$183.58
52w lo$136.09
Vol2.16M
As ofAug 13
The Verdict

Hold

Our score +0.29

Short+0.26
Medium+0.43
Long+0.07

computed 2026-08-12

By the Numbers

Becton, Dickinson and Company

Healthcare · Medical Instruments & Supplies

Market cap$49.57B
Enterprise value$66.10B
Trailing P/E31.48x
Forward P/E13.65x
EV / EBITDA10.80x
P / S (ttm)2.20x
Profit margin4.2%
Return on equity6.6%
Revenue growth+5.4%
Earnings growth-31.4%
Debt / equity68.84
Risk Metrics
Beta vs SPX0.46
Corr SPX0.27
Annual vol27.6%
Annual ret+3.3%
Sharpe0.12
Max DD-33.7%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.08
Sector+0.12
Technical+0.20
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-12

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$184.75$185.26$181.41$181.972.16M
Aug 12$177.61$183.75$177.13$183.581.55M
Aug 11$178.35$181.79$178.35$181.411.52M
Aug 10$176.49$179.79$175.63$179.631.77M
Aug 7$175.26$177.55$173.29$176.861.85M